Related Experiment Video
Updated: Jul 4, 2026
12:43
Parallel-plate Flow Chamber and Continuous Flow Circuit to Evaluate Endothelial Progenitor Cells under Laminar Flow Shear Stress
Published on: January 17, 2012
Pressure-driven perfusion culture microchamber array for a parallel drug cytotoxicity assay
Shinji Sugiura1, Jun-ichi Edahiro, Kyoko Kikuchi
1Research Center of Advanced Bionics, National Institute of Advanced Industrial Science and Technology, Central 5th, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8565, Japan.
Biotechnology and Bioengineering
|June 17, 2008
Summary
A novel perfusion culture chip enables parallel drug cytotoxicity assays using an 8x5 microchamber array. This microfluidic device simplifies drug screening and offers a platform for high-throughput analysis.
Area of Science:
- Biotechnology
- Microfluidics
- Drug Discovery
Background:
- Drug cytotoxicity assays are crucial for identifying effective therapeutics.
- Existing methods can be time-consuming and require specialized equipment.
- Microfluidic devices offer potential for miniaturized and high-throughput biological assays.
Purpose of the Study:
- To develop and validate a pressure-driven perfusion culture chip for parallel drug cytotoxicity assays.
- To create a user-friendly microfluidic platform for drug screening.
Main Methods:
- Fabrication of a polydimethylsiloxane (PDMS) chip using multilayer photolithography and replica molding.
- Design of an 8x5 array of microchambers with independent perfusion channels.
- Implementation of a pressure-driven system for uniform cell loading and perfusion culture.
Main Results:
- Successful parallel drug cytotoxicity assay performed on the chip.
- Analysis of cytotoxic effects of seven anticancer drugs.
- Demonstration of uniform cell loading and perfusion without cross-contamination.
Conclusions:
- The developed pressure-driven perfusion culture chip is a viable platform for parallel drug cytotoxicity assays.
- The chip's design facilitates easy operation and high-throughput drug screening.
- This microfluidic approach offers an advantageous solution for future drug discovery efforts.
